Life Expectancy in China

What life expectancy actually measures

Life expectancy at birth estimates how long a newborn would live if current age-specific mortality rates stayed constant. It is not a prediction for a particular child and it is not the same as healthy life expectancy. In China's case, it is useful because it condenses several decades of system change: vaccination, safer births, antibiotics, clean water, poverty reduction, basic insurance expansion, hospital growth, and public-health campaigns.

The most important interpretive point is that the indicator changes when deaths shift by age and cause. Reducing infant deaths raises life expectancy sharply because it preserves many potential years of life. Reducing maternal mortality affects families and population health even when the number of deaths is smaller. At later ages, gains depend more on cardiovascular disease, stroke, cancer, chronic respiratory disease, diabetes, dementia, injury, and infection control among older adults. China's future life-expectancy gains will therefore be harder than the early gains from child survival and infectious-disease control.

Why China improved so much

China's improvement reflects broad development, not only hospitals. WHO materials on child and maternal survival describe large reductions after 1990, including infant mortality falling from more than 50.2 per 1,000 live births in 1991 to 8.9 in 2014, and maternal mortality reaching 21.7 per 100,000 in 2014, 76 percent below 1990. WHO also points to antenatal care, folic acid, hospital delivery, rural and urban insurance expansion, basic public health services, and immunization as part of the improvement.

The National Health Commission's 2025 report on 2024 life expectancy attributed recent gains to health-prioritizing strategies, Healthy China policies, and lifestyle factors, while also acknowledging continuing pressure from infectious and chronic noncommunicable diseases. That balance is important. Life expectancy is no longer mainly a story of building basic survival. It is increasingly a story of whether the system can prevent stroke, control hypertension, reduce smoking-related disease, manage cancer earlier, and support older adults with multiple conditions.

How to read the issue

Strategic meaning

For health-system strategy, life expectancy is a scoreboard rather than a playbook. It shows that China's system has produced major population-health gains, but it does not say which intervention should come next. The next phase points toward chronic disease prevention, better primary care, emergency response for stroke and heart disease, cancer screening and treatment pathways, mental health, environmental health, and long-term care.

For companies, investors, and policy readers, the useful move is to translate the national number into disease-specific and setting-specific pathways. A hypertension platform, an oncology diagnostic, a rehabilitation service, or a long-term care model should be evaluated against the mortality and disability problem it can realistically change, the payer that can fund it, and the provider level that can deliver it at scale.

Research anchors